Medicamen Biotech Share Price
Know More₹478.95 1.45 (0.30%)
04:01 PM, 4-Mar-2025₹479.15-0.95 (-0.20%)
03:48 PM, 4-Mar-2025BSE : 531146
NSE : MEDICAMEQ
Sector : Health care
ISIN Code : INE646B01010
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 04-Mar-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 609 |
Traded Value (₹ Cr) | 0.04 |
Volume (Shares) | 762 |
Face Value (₹) | 10 |
52-Week High (₹) | 630.00 |
52-Week High Date | 06-Dec-2024 |
52-Week Low (₹) | 356.75 |
52-Week Low Date | 13-Mar-2024 |
All Time High (₹) | 1,219.00 |
All Time High Date | 01-Sep-2022 |
All Time Low (₹) | 2.25 |
All Time Low Date | 18-Apr-2001 |
Medicamen Biotech Ltd
Market News
Medicamen Biotec Announcement
Medicamen Biotech Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 609 |
| EPS - TTM (₹) [C] | 6.61 |
| P/E Ratio (X) [C] | 72.49 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 19-Sep-2024 |
| Dividend Yield (%) | 0.21 |
| Book Value Share (₹) [C] | 169.82 |
| P/B Ratio (₹) [C] | 2.82 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 76 | 0.02 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 471.30 509.90 |
| Week Low/High (₹) | 471.30 552.00 |
| Month Low/High (₹) | 418.15 561.00 |
| Year Low/High (₹) | 355.45 630.00 |
| All time Low/High (₹) | 2.25 1,225.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -11.62% | -11.90% | -2.16% | -2.06% |
| 1 Month | -1.79% | -1.40% | -7.12% | -6.98% |
| 3 Month | -9.38% | -9.29% | -9.84% | -9.75% |
| 6 Month | 11.74% | 11.89% | -11.37% | -12.37% |
| 1 Year | -0.06% | 0.14% | -1.19% | -1.44% |
| 3 Year | -22.92% | -23.21% | 34.34% | 35.93% |
Company Info
Company Information
Non Executive Director : Sanjay Bansal
Chairman (Non-Executive) : Rahul Bishnoi
Non Executive Director : Ashwani Kumar Sharma
Independent Director : Harish Pande
Non Executive Director : S K Singh
Independent Director : Arun Kumar
Company Sec. & Compli. Officer : Parul Choudhary
Independent Director : Sumita Dwivedi
Non Executive Director : Vimal Kumar Shrawat.
Independent Director : Sangeeta Bishnoi
Independent Director : Ravi Kumar Bansal
Registered Office: 1506 Chiranjiv Tower 43, Nehru Place,New Delhi,New Delhi-110019 Ph: 91-11-47589500
Email:cs@medicamen.com
FAQs about Medicamen Biotech Ltd
1. What's the Medicamen Biotech Ltd share price today?
Medicamen Biotech Ltd share price was Rs 478.95 at 04:01 PM IST on 4th Mar 2025. Medicamen Biotech Ltd share price was up by 0.30% over the previous closing price of Rs 477.50. Medicamen Biotech Ltd share price trend:
- Last 1 Month: Medicamen Biotech Ltd share price moved down by 1.79% on BSE
- Last 3 Months: Medicamen Biotech Ltd share price moved down by 9.38% on BSE
- Last 12 Months: Medicamen Biotech Ltd share price moved down by 0.06% on BSE
- Last 3 Years: Medicamen Biotech Ltd price moved down by 22.92% on BSE
2. How can I quickly analyse the performance of the Medicamen Biotech Ltd stock?
The performance of the Medicamen Biotech Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 72.49
- Price to book value ratio is 2.82
- Dividend yield of 0.21
- The EPS (trailing 12 months) of the Medicamen Biotech Ltd stock is Rs 6.61
3. What is the market cap of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a market capitalisation of Rs 609 crore.
4. What is Medicamen Biotech Ltd's 52-week high/low share price?
The Medicamen Biotech Ltd’s 52-week high share price is Rs 630.00 and 52-week low share price is Rs 356.75.
5. Is the Medicamen Biotech Ltd profitable?
On a consolidated basis, Medicamen Biotech Ltd reported a profit of Rs 2.52 crore on a total income of Rs 41.28 crore for the quarter ended 2024. For the year ended Dec 2024, Medicamen Biotech Ltd had posted a profit of Rs 2.92 crore on a total income of Rs 45.28 crore.
6. Which are Medicamen Biotech Ltd’s peers in the Health care sector?
Medicamen Biotech Ltd’s top 5 peers in the Health care sector are Fermenta Biotec., Kwality Pharma, NGL Fine Chem, Medicamen Biotec, Bharat Parenter., Nectar Lifesci., Wanbury.
7. Who owns how much in Medicamen Biotech Ltd?
Key changes to the Medicamen Biotech Ltd shareholding are as follows:
- Promoter holding in Medicamen Biotech Ltd has gone down to 42.99 per cent as of Dec 2024 from 43.21 per cent as of Mar 2024.
